Institutional investors purchased a net $1.4 million shares of RGEN during the quarter ended June 2014, and now own 88.34% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EAGLE ASSET MANAGEMENT, INC. Bought 196.6 Thousand shares of Repligen Corp